Stoke Therapeutics (NASDAQ:STOK) Director Sells 42,461 Shares
MarketBeat
Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) Director Edward Md Kaye sold 42,461 shares of the stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $25.09, for a total value of $1,065,346.49. Following the completion of the sale, the director owned 49,124 shares of the company's stock, valued at approximately $1,232,521.16. This trade represents a 46.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
NASDAQ:STOK